Form 4 Filing for Relay Therapeutics, Inc.

This filing details a transaction by SVF Pauling (Cayman) Ltd, a significant owner, involving 6,000,000 shares of common stock in Relay Therapeutics, Inc. The transaction occurred on August 25, 2026, with a price per share of $19.40. Following this transaction, the post-transaction number of shares owned is 21,904,963. The filing also clarifies that SVF Pauling (Cayman) Limited is a subsidiary of SoftBank Vision Fund (AIV M2) L.P., and SB Investment Advisers (UK) Limited acts as the Alternative Investment Fund Manager responsible for managing these investments. The ownership is noted as indirect.